vaccine

Vaccine for at-risk children by next month, says Covid Task Force Chief NK Arora

Dr. NK Arora, chairman of the country's Covid Task Force, told NDTV today that vaccination for children with comorbidities will…

3 years ago

Omicron: Monoclonal Antibody treatment will be a game changer, experts claim

“Monoclonal antibody should be given to high-risk patients, which attacks the spike protein and arrests the virus when it does…

3 years ago

United States: Booster shots authorized for all adults

According to Pfizer and Moderna, the United States today extended the authorisation of Covid-19 vaccine boosters to all persons aged…

3 years ago

Researchers identified New potential treatment for Covid-19

During a recent study, researchers discovered a potential new treatment that inhibits the replication of SARS-CoV-2, the virus that causes…

3 years ago

COVID-19 vaccine Corbevax to be rolled out by Nov end, says Managing Director of Biological E Limited

To provide further momentum to the ongoing nationwide vaccination drive, the COVID-19 vaccine Corbevax vaccine will be rolled out by…

3 years ago

After 100 years, India is still looking for new Tuberculosis vaccinations

In order to meet India's goal of eradicating TB by 2025, scientists at the Indian Council of Medical Research have…

3 years ago

Sanofi says good results from flu vaccine with mRNA booster study

Sanofi, a French healthcare business, announced on Wednesday that the first research into a high-dose influenza vaccination with a COVID-19…

3 years ago

The latest on WHO: recommended influenza vaccinations for newly developed strains may be found here

Learn more about the flu virus. Seasonal influenza, or flu, is an infectious virus that causes respiratory disease. It is,…

3 years ago

To combat deteriorating vaccine efficacy, the US has approved the Covid booster shot

The effectiveness of the coronavirus vaccine is deteriorating with time, according to US regulators, who have authorised booster shots for…

3 years ago

COVID-19 vaccine: J&J doses may not arrive until November, Zydus Cadila is expected next, and Covaxin expansion is a priority

The government expects the first doses of Johnson & Johnson's (J&J) single-shot vaccine to arrive in November or December, according…

3 years ago